FDA develops its own AI for clinical reviews, investigations and more

Подробнее о видео

The Food and Drug Administration (FDA) launched a new generative AI tool it hopes will make employees more efficient on everything from clinical evaluations to inspections. The AI is called Elsa, and it was developed in-house to help with reading, writing and summarizing.

“As we learn how employees are using the tool, our development team will be able to add capabilities and grow with the needs of employees and the agency,” FDA Chief AI Officer Jeremy Walsh, said in a statement.

Full story:

Follow Straight Arrow News on social media:
Facebook:
Twitter:
Instagram:
TikTok:
Threads:

For more SAN content:
Sign up for our weekly newsletters:

Download the SAN App!
Apple:
Google Play: